OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their robustness in expressing complex molecules. Enhancing these processes involves adjusting various factors, including cell line selection, media formulation, CHO Cell and bioreactor settings. A key goal is to amplify antibody yield while lowering production costs a